National Multiple Sclerosis Society

Disability
Theory and models Disability theory Ableism / Disablism Medical model Social model
Education Mainstreaming Individualized Education Program (IEP) Special needs Special school Special education Learning disability
Therapy Physical Occupational Speech
Societal implications Disability rights movement Inclusion Normalisation People-first language Pejorative terms
Personal assistance Personal care assistant (ADLs) Orthotics and braces Prosthetics Assistive technology Assisted living Mobility aid Physical accessibility Universal design Web accessibility
Socioeconomic assistance Social Security Disability Insurance Supplemental Security Income Ticket to Work Disability Living Allowance Disabled students allowance Disabled Persons Railcard Freedom Pass Assured Income for the Severely Handicapped
Groups Organizations National Telecommuting Institute Society for Disability Studies Disabled Peoples' International (DPI) Visitability
Disabled sports Special Olympics Paralympic Games Deaflympics Invictus Games
Culture Disability in the arts Disability art Disability in the media
Disability portal Disability Lists

The National Multiple Sclerosis Society, is a United States-based, non-profit organization, and its network of chapters nationwide help people affected by multiple sclerosis by funding research, driving change through advocacy, facilitating professional education, and providing programs and services that help people with multiple sclerosis and their families. It is headquartered in New York City.

Founded in 1946, originally under the name Association for Advancement of Research on Multiple Sclerosis,^[1] the National Multiple Sclerosis Society supports more multiple sclerosis research, offers more services for people diagnosed with multiple sclerosis, provides more professional education programs, and furthers more advocacy efforts than any other multiple sclerosis organization in the world.^[2]

Fund raising events

Walk MS
Bike MS
Challenge Walk MS
MuckFest MS

Research

The National Multiple Sclerosis Society supports and funds research activities in all research stages, including early discovery research, translational research that develops promising laboratory results into treatments, and clinical trials to find out whether the treatments work. In 2012, the Society invested $44 million in over 350 new and ongoing projects.^[3]^[4]

References

External links

Multiple sclerosis and other demyelinating diseases of CNS (G35–G37, 340–341)

Signs and symptoms	Ataxia Depression Diplopia Dysarthria Dysphagia Fatigue Incontinence Neurological fatigue Nystagmus Optic neuritis Pain Uhthoff's phenomenon Dawson's fingers

Diagnosis and evolution following	Diagnostic criteria for MS McDonald criteria Poser criteria EDSS Clinically isolated syndrome

Investigation	Pathophysiology Experimental autoimmune encephalomyelitis Multiple sclerosis drug pipeline Multiple sclerosis research

Approved Treatment	Interferon beta 1b Glatiramer acetate Interferon beta 1a Mitoxantrone Natalizumab Fingolimod Teriflunomide Dimethyl fumarate Alemtuzumab Daclizumab

Borderline forms	Acute disseminated encephalomyelitis Balo concentric sclerosis Neuromyelitis optica Marburg multiple sclerosis Schilder's disease Tumefactive multiple sclerosis (Autoimmune PNS diseases like Guillain-Barré syndrome and CIDP are normally set apart) AntiMOG associated encephalomyelitis

Other	List of people with multiple sclerosis List of multiple sclerosis organizations

This article is issued from Wikipedia - version of the 11/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.